NovoCure (NVCR) Gross Profit (QoQ) (2014 - 2026)
NovoCure (NVCR) Gross Profit (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.61 Bn | 175.32 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn |
| 3 | Medtronic | 108.22 Bn | 99.00 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.29 Bn | 66.84 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn |
| 6 | Dexcom | 28.31 Bn | 27.19 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.03 Bn | 25.75 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 24.04 Bn | 20.91 Bn | 2.07 Bn |
| 10 | NovoCure | 2.02 Bn | 1.58 Bn | 142.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.44% |
| Mar 31, 2026 | 2.22% |
| Dec 31, 2025 | 7.93% |
| Sep 30, 2025 | 4.38% |
| Jun 30, 2025 | 0.74% |
| Mar 31, 2025 | -8.86% |
| Dec 31, 2024 | 6.75% |
| Sep 30, 2024 | 3.48% |
| Jun 30, 2024 | 10.39% |
| Mar 31, 2024 | 3.54% |
| Dec 31, 2023 | 6.30% |
| Sep 30, 2023 | 3.47% |
| Jun 30, 2023 | -0.58% |
| Mar 31, 2023 | -7.01% |
| Dec 31, 2022 | -1.69% |
| Sep 30, 2022 | -9.89% |
| Jun 30, 2022 | 2.32% |
| Mar 31, 2022 | 6.08% |
| Dec 31, 2021 | 0.12% |
| Sep 30, 2021 | -1.45% |